Treatment for Necrosis

Waitlist Available · 18+ · All Sexes · Versailles, France

This study is evaluating whether the Persona Partial Knee System is safe and effective for the treatment of knee osteoarthritis.

See full description

About the trial for Necrosis

Eligible Conditions
Necrosis · Conditional Tibial Condyle or Plateau Fractures · Avascular Necrosis · Arthritis · Conditional Revision of the Articular Surface · Osteoarthritis · Posttraumatic Osteoarthritis

Treatment Groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.


This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
The patient has been involved in a study-related process in which they have been given information about the study so that they can give informed consent. show original
The patient agrees to sign and date the form that approves the use of their information for research purposes show original
The patient is a good candidate for the Persona Partial Knee, which is a commercially available implant, as long as they participate in the study. show original
Patient is at least 18 years of age
The patient qualifies for knee surgery based on a physical examination and their medical history show original
The patient is willing and able to complete the scheduled study procedures and follow-up evaluations. show original
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 10 years
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 years
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 10 years.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome and 1 secondary outcome in patients with Necrosis. Measurement will happen over the course of 10 years.

a questionnaire completed by the Patient and assesses his/her General health Status. The EQ5D is used to derive a Quality of life index used for health economics considerations.
Oxford Knee Score
A Patient reported functional outcome score for knee arthroplasty

Patient Q & A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Necrosis by sharing your contact details with the study coordinator.